<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03472456</url>
  </required_header>
  <id_info>
    <org_study_id>6953</org_study_id>
    <nct_id>NCT03472456</nct_id>
  </id_info>
  <brief_title>Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?</brief_title>
  <official_title>Articaine or Eugenol: a Study on the Choice of Endodontic Medication in the Emergency Management of Irreversible Pulpitis of a Mature Permanent Tooth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to determine which of the two commonly used endodontic
      medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in
      irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the
      pain felt by patients will be carried out a few days apart. The supposed results are that the
      medications are equivalent in terms of effectiveness on the pain, but could then present
      different economic arguments
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive
      endodontic medications (Eugenol or Articaine) in order to determine which one is the more
      efficient to control the pain.

      These patients would have received the same medication without this study. That's why this is
      an obsevationnal study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2018</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain evolution (decrease or increase the intensity of the pain)</measure>
    <time_frame>7 days</time_frame>
    <description>Evolution of pain (using a score of 0 to 10)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pulpitides</condition>
  <condition>Endodontic Inflammation</condition>
  <condition>Toothaches</condition>
  <condition>Operative Dentistry</condition>
  <arm_group>
    <arm_group_label>Articaïne</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Eugénol</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne</intervention_name>
    <description>Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne</description>
    <arm_group_label>Articaïne</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol</intervention_name>
    <description>Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol</description>
    <arm_group_label>Eugénol</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the University Hospital (Dental Service) of Strasbourg (HUS)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient, major, affiliated to a social health insurance scheme

          -  Patient having agreed to participate in the study

          -  Urgent consultant patient for irreversible pulpitis

          -  Patient understanding French

        Exclusion Criteria:

          -  Refusal of the patient to participate in the study

          -  Impossibility of performing the surgical procedure

          -  Impossibility to give the subject information enlightened (difficulty of understanding
             ...)

          -  Subject under the protection of justice, or under guardianship

          -  General contraindication to endodontic treatment in 2 sessions (high risk of
             infectious endocarditis, for example)

          -  Chronic intake of analgesic drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Damien OFFNER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Damien OFFNER</last_name>
    <phone>03 88 11 69 76</phone>
    <email>damien.offner@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien OFFNER</last_name>
      <phone>03 88 11 69 76</phone>
      <email>damien.offner@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Marie MUSSET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriel FERNANDEZ DE GRADO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2018</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Pulpitis</mesh_term>
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Eugenol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

